{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:52:22Z","timestamp":1785423142019,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T00:00:00Z","timestamp":1201132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T00:00:00Z","timestamp":1201132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.leu.2405104","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:31:17Z","timestamp":1201177877000},"page":"783-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease"],"prefix":"10.1038","volume":"22","author":[{"given":"A","family":"Sergeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Molldrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,24]]},"reference":[{"key":"BF2405104_CR1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V77.6.1131.1131","volume":"77","author":"JC Gasson","year":"1991","unstructured":"Gasson JC . Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 1131\u20131145.","journal-title":"Blood"},{"key":"BF2405104_CR2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V68.5.1178.1178","volume":"68","author":"DC Young","year":"1986","unstructured":"Young DC, Griffin JD . Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178\u20131181.","journal-title":"Blood"},{"key":"BF2405104_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/314361a0","volume":"314","author":"RH Weisbart","year":"1985","unstructured":"Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC . Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 1985; 314: 361\u2013363.","journal-title":"Nature"},{"key":"BF2405104_CR4","first-page":"323","volume":"191","author":"D Metcalf","year":"1985","unstructured":"Metcalf D . Molecular control of granulocyte and macrophage production. Prog Clin Biol Res 1985; 191: 323\u2013337.","journal-title":"Prog Clin Biol Res"},{"key":"BF2405104_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0165-2478(02)00295-X","volume":"86","author":"S Vasilijic","year":"2003","unstructured":"Vasilijic S, Colic M, Vucevic D . Granulocyte-macrophage colony stimulating factor is an anti-apoptotic cytokine for thymic dendritic cells and a significant modulator of their accessory function. Immunol Lett 2003; 86: 99\u2013112.","journal-title":"Immunol Lett"},{"key":"BF2405104_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/stem.5530110311","volume":"11","author":"RD Irons","year":"1993","unstructured":"Irons RD, Stillman WS . Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells 1993; 11: 235\u2013242.","journal-title":"Stem Cells"},{"key":"BF2405104_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1126\/science.3484837","volume":"231","author":"MM Le Beau","year":"1986","unstructured":"Le Beau MM, Westbrook CA, Diaz MO, Larson RA, Rowley JD, Gasson JC et al. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 1986; 231: 984\u2013987.","journal-title":"Science"},{"key":"BF2405104_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1365-2567.1999.00806.x","volume":"97","author":"A Meager","year":"1999","unstructured":"Meager A, Wadhwa M, Bird C, Dilger P, Thorpe R, Newsom-Davis J et al. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology 1999; 97: 526\u2013532.","journal-title":"Immunology"},{"key":"BF2405104_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/cimm.2000.1704","volume":"204","author":"RP Revoltella","year":"2000","unstructured":"Revoltella RP, Laricchia Robbio L, Liberati AM, Reato G, Foa R, Funaro A et al. Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro. Cell Immunol 2000; 204: 114\u2013127.","journal-title":"Cell Immunol"},{"key":"BF2405104_CR10","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V91.6.2054","volume":"91","author":"M Svenson","year":"1998","unstructured":"Svenson M, Hansen MB, Ross C, Diamant M, Rieneck K, Nielsen H et al. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood 1998; 91: 2054\u20132061.","journal-title":"Blood"},{"key":"BF2405104_CR11","first-page":"1353","volume":"5","author":"M Wadhwa","year":"1999","unstructured":"Wadhwa M, Skog AL, Bird C, Ragnhammar P, Lilljefors M, Gaines-Das R et al. Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF. Clin Cancer Res 1999; 5: 1353\u20131361.","journal-title":"Clin Cancer Res"},{"key":"BF2405104_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1006\/clim.2000.4999","volume":"99","author":"G Ullenhag","year":"2001","unstructured":"Ullenhag G, Bird C, Ragnhammar P, Fr\u00f6din JE, Strig\u00e5rd K, \u00d6sterborg A et al. Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation. Clin Immunol 2001; 99: 65\u201374.","journal-title":"Clin Immunol"},{"key":"BF2405104_CR13","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood.V93.8.2653.408k07_2653_2659","volume":"93","author":"DG McNeel","year":"1999","unstructured":"McNeel DG, Schiffman K, Disis ML . Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1999; 93: 2653\u20132659.","journal-title":"Blood"},{"key":"BF2405104_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.190.6.875","volume":"190","author":"T Kitamura","year":"1999","unstructured":"Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875\u2013880.","journal-title":"J Exp Med"},{"key":"BF2405104_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","volume":"103","author":"K Uchida","year":"2004","unstructured":"Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004; 103: 1089\u20131098.","journal-title":"Blood"},{"key":"BF2405104_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02990843","volume":"13","author":"P Ragnhammar","year":"1996","unstructured":"Ragnhammar P, Wadhwa M . Neutralising antibodies to granulocyte-macrophage colony stimulating factor (GM-CSF) in carcinoma patients following GM-CSF combination therapy. Med Oncol 1996; 13: 161\u2013166.","journal-title":"Med Oncol"},{"key":"BF2405104_CR17","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.vaccine.2004.03.002","volume":"22","author":"M Eisenblatter","year":"2004","unstructured":"Eisenblatter M, Stahl-Hennig C, Kuate S, Stolte N, Jasny E, Hahn H et al. Induction of neutralising antibodies restricts the use of human granulocyte\/macrophage colony stimulating factor for vaccine studies in rhesus macaques. Vaccine 2004; 22: 3295\u20133302.","journal-title":"Vaccine"},{"key":"BF2405104_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V88.1.202.202","volume":"88","author":"ML Disis","year":"1996","unstructured":"Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 1996; 88: 202\u2013210.","journal-title":"Blood"},{"key":"BF2405104_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1034\/j.1600-065X.2002.18813.x","volume":"188","author":"G Dranoff","year":"2002","unstructured":"Dranoff G . GM-CSF-based cancer vaccines. Immunol Rev 2002; 188: 147\u2013154.","journal-title":"Immunol Rev"},{"key":"BF2405104_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3816\/CLC.2000.n.021","volume":"2","author":"K Schiffman","year":"2000","unstructured":"Schiffman K, Disis ML . HER2\/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2\/neu-expressing cancers. Clin Lung Cancer 2000; 2: 74\u201377.","journal-title":"Clin Lung Cancer"},{"key":"BF2405104_CR21","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","volume":"88","author":"J Molldrem","year":"1996","unstructured":"Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996; 88: 2450\u20132457.","journal-title":"Blood"},{"key":"BF2405104_CR22","first-page":"2675","volume":"59","author":"JJ Molldrem","year":"1999","unstructured":"Molldrem JJ, Lee PP, Wang C, Champlin RE, Davis MM . A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res 1999; 59: 2675\u20132681.","journal-title":"Cancer Res"},{"key":"BF2405104_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.1041400219","volume":"140","author":"T Kitamura","year":"1989","unstructured":"Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989; 140: 323\u2013334.","journal-title":"J Cell Physiol"},{"key":"BF2405104_CR24","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.4049\/jimmunol.164.7.3887","volume":"164","author":"RJ Harris","year":"2000","unstructured":"Harris RJ, Pettitt AR, Schmutz C, Sherrington PD, Zuzel M, Cawley JC et al. Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes. J Immunol 2000; 164: 3887\u20133893.","journal-title":"J Immunol"},{"key":"BF2405104_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2249.1996.11704.x","volume":"104","author":"M Wadhwa","year":"1996","unstructured":"Wadhwa M, Bird C, Fagerberg J, Gaines-Das R, Ragnhammar P, Mellstedt H et al. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy. Clin Exp Immunol 1996; 104: 351\u2013358.","journal-title":"Clin Exp Immunol"},{"key":"BF2405104_CR26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.V77.5.1033.1033","volume":"77","author":"Y Kanakura","year":"1991","unstructured":"Kanakura Y, Cannistra SA, Brown CB, Nakamura M, Seelig GF, Prosise WW et al. Identification of functionally distinct domains of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies. Blood 1991; 77: 1033\u20131043.","journal-title":"Blood"},{"key":"BF2405104_CR27","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.V90.7.2529","volume":"90","author":"JJ Molldrem","year":"1997","unstructured":"Molldrem JJ, Clave E, Jiang YZ, Mavroudis D, Raptis A, Hensel N et al. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units. Blood 1997; 90: 2529\u20132534.","journal-title":"Blood"},{"key":"BF2405104_CR28","first-page":"61","volume":"112","author":"M Wadhwa","year":"2003","unstructured":"Wadhwa M, Mellstedt H, Small E, Thorpe R . Immunogenicity of GM-CSF products in cancer patients following immunostimulatory therapy with GM-CSF. Dev Biol (Basel) 2003; 112: 61\u201367.","journal-title":"Dev Biol (Basel)"},{"key":"BF2405104_CR29","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1182\/blood.V69.6.1771.1771","volume":"69","author":"E Vellenga","year":"1987","unstructured":"Vellenga E, Young DC, Wagner K, Wiper D, Ostapovicz D, Griffin JD . The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771\u20131776.","journal-title":"Blood"},{"key":"BF2405104_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0014-5793(98)01668-8","volume":"442","author":"N Tanaka","year":"1999","unstructured":"Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, Nakata K . Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 1999; 442: 246\u2013250.","journal-title":"FEBS Lett"},{"key":"BF2405104_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa062505","volume":"356","author":"K Uchida","year":"2007","unstructured":"Uchida K, Beck DC, Yamamoto T, Berclaz PY, Abe S, Staudt MK et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356: 567\u2013579.","journal-title":"N Engl J Med"},{"key":"BF2405104_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s001340050563","volume":"24","author":"A Gacouin","year":"1998","unstructured":"Gacouin A, Le Tulzo Y, Suprin E, Briens E, Bernard M, Camus C et al. Acute respiratory failure caused by secondary alveolar proteinosis in a patient with acute myeloid leukemia: a case report. Intensive Care Med 1998; 24: 265\u2013267.","journal-title":"Intensive Care Med"},{"key":"BF2405104_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0300-2977(00)00025-5","volume":"56","author":"CA Birsak","year":"2000","unstructured":"Birsak CA, van Rossem RN, Nijhuis-Heddes JM, Maartense E . Pulmonary alveolar proteinosis: a complication in patients with hematologic malignancy. Neth J Med 2000; 56: 193\u2013197.","journal-title":"Neth J Med"},{"key":"BF2405104_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.bmt.1700915","volume":"20","author":"M Rodriguez-Luaces","year":"1997","unstructured":"Rodriguez-Luaces M, Lafuente A, Martin MP, Mateos P, Ojeda E, Hernandez-Navarro F . Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukaemia. Bone Marrow Transplant 1997; 20: 507\u2013510.","journal-title":"Bone Marrow Transplant"},{"key":"BF2405104_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0145-2126(01)00178-3","volume":"26","author":"N Shoji","year":"2002","unstructured":"Shoji N, Ito Y, Kimura Y, Nishimaki J, Kuriyama Y, Tauchi T et al. Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy. Leuk Res 2002; 26: 591\u2013595.","journal-title":"Leuk Res"},{"key":"BF2405104_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2169\/internalmedicine.42.187","volume":"42","author":"T Ohnishi","year":"2003","unstructured":"Ohnishi T, Yamada G, Shijubo N, Takagi-Takahashi Y, Itoh T, Takahashi H et al. Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome. Intern Med 2003; 42: 187\u2013190.","journal-title":"Intern Med"},{"key":"BF2405104_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0167-5699(95)80161-8","volume":"16","author":"B Klein","year":"1995","unstructured":"Klein B, Brailly H . Cytokine-binding proteins: stimulating antagonists. Immunol Today 1995; 16: 216\u2013220.","journal-title":"Immunol Today"},{"key":"BF2405104_CR38","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4049\/jimmunol.151.3.1235","volume":"151","author":"FD Finkelman","year":"1993","unstructured":"Finkelman FD, Madden KB, Morris SC, Holmes JM, Boiani N, Katona IM et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol 1993; 151: 1235\u20131244.","journal-title":"J Immunol"},{"key":"BF2405104_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.coi.2006.07.005","volume":"18","author":"S Rusakiewicz","year":"2006","unstructured":"Rusakiewicz S, Molldrem JJ . Immunotherapeutic peptide vaccination with leukemia-associated antigens. Curr Opin Immunol 2006; 18: 599\u2013604.","journal-title":"Curr Opin Immunol"},{"key":"BF2405104_CR40","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/79526","volume":"6","author":"JJ Molldrem","year":"2000","unstructured":"Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000; 6: 1018\u20131023.","journal-title":"Nat Med"},{"key":"BF2405104_CR41","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1182\/blood.V99.9.3272","volume":"99","author":"OA Elisseeva","year":"2002","unstructured":"Elisseeva OA, Oka Y, Tsuboi A, Ogata K, Wu F, Kim EH et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood 2002; 99: 3272\u20133279.","journal-title":"Blood"},{"key":"BF2405104_CR42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood.V72.4.1329.1329","volume":"72","author":"DC Kaufman","year":"1988","unstructured":"Kaufman DC, Baer MR, Gao XZ, Wang ZQ, Preisler HD . Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in vitro blast cell enrichment. Blood 1988; 72: 1329\u20131332.","journal-title":"Blood"},{"key":"BF2405104_CR43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1006\/cyto.1999.0631","volume":"12","author":"S Bi","year":"2000","unstructured":"Bi S, Gao X, Devemy E, Chopra H, Venugopal P, Raza A et al. Cytokine production by in vitro processed and unprocessed haematopoietic cells. Cytokine 2000; 12: 1124\u20131128.","journal-title":"Cytokine"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:12:42Z","timestamp":1684203162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF2405104"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405104","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,24]]},"assertion":[{"value":"14 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}